13F-HR filed by RTW INVESTMENTS, LP
RTW INVESTMENTS, LP filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 40 holding rows worth $1,386,575,000.
- Accession
- 0001493152-18-011640
- Filer
- CIK 1493215
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A holdings report, 40 entries on the cover page, a total value of $1,386,575,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,386,575,000 with VALUE read as thousands by filing date, 13F file number 028-16670. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerRTW MASTER FUND, LTD.028-16671
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 14,969,744 | $289,448,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 2,079,555 | $149,208,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 4,073,690 | $137,406,000 | thousands by filing date | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 978,551 | $129,345,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 8,299,542 | $112,874,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 5,044,813 | $61,799,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 903,672 | $50,009,000 | thousands by filing date | |
| LIVANOVA PLC | G5509L101 | SHS | 431,000 | $43,022,000 | thousands by filing date | |
| LA JOLLA PHARMACEUTICAL CO | 503459604 | COM PAR $.0001 2 | 1,345,881 | $39,259,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 13,541,997 | $38,324,000 | thousands by filing date | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 5,165,499 | $37,708,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 352,200 | $34,688,000 | thousands by filing date | |
| MASIMO CORP COM | 574795100 | Stock | 249,543 | $24,368,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 675,771 | $22,753,000 | thousands by filing date | |
| VERICEL CORP | 92346J108 | COM | 2,217,916 | $21,514,000 | thousands by filing date | |
| AGENUS INC | 00847G705 | COM NEW | 9,375,451 | $21,282,000 | thousands by filing date | |
| QIAGEN NV | N72482123 | SHS NEW | 529,385 | $19,143,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 409,370 | $15,474,000 | thousands by filing date | |
| CORIUM INTL INC | 21887L107 | COM | 1,923,217 | $15,405,000 | thousands by filing date | |
| ILLUMINA INC | 452327109 | COM | 49,658 | $13,869,000 | thousands by filing date | |
| MYOKARDIA INC | 62857M105 | COM | 261,395 | $12,978,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 1,474,156 | $10,201,000 | thousands by filing date | |
| POLARITYTE INC | 731094108 | COM | 426,670 | $10,044,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 764,532 | $9,358,000 | thousands by filing date | |
| BOVIE MEDICAL CORP | 10211F100 | COM | 2,082,137 | $9,057,000 | thousands by filing date | |
| ELECTROCORE INC | 28531P103 | COM | 505,000 | $8,338,000 | thousands by filing date | |
| NUVECTRA CORP | 67075N108 | COM | 383,030 | $7,864,000 | thousands by filing date | |
| VIVEVE MED INC | 92852W204 | COM NEW | 2,861,023 | $7,782,000 | thousands by filing date | |
| ODONATE THERAPEUTICS INC | 676079106 | COM | 276,368 | $6,102,000 | thousands by filing date | |
| NEURONETICS INC | 64131A105 | COM | 190,000 | $5,056,000 | thousands by filing date | |
| TRANSPORTATION & LOGISTI | 438083107 | COM | 226,431 | $4,619,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 2,644,346 | $3,543,000 | thousands by filing date | |
| VIVUS INC | 928551AA8 | CONV BND | 4,000,000 | $3,140,000 | thousands by filing date | |
| PROTEOSTASIS THERAPEUTICS IN | 74373B109 | COM | 1,077,408 | $3,006,000 | thousands by filing date | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 25,559 | $2,118,000 | thousands by filing date | |
| NOVUS THERAPEUTICS INC | 67011N105 | COM | 301,799 | $2,113,000 | thousands by filing date | |
| TapImmune Inc | 876033408 | COM | 200,000 | $1,886,000 | thousands by filing date | |
| BELLICUM PHARMACEUTICALS INC | 079481107 | COM | 150,289 | $1,109,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 176,372 | $935,000 | thousands by filing date | |
| MOTUS GI HLDGS INC | 62014P108 | COM | 59,478 | $428,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-18-011640 | this filing | 2018-08-14 | acceptance time not in the bulk data set |